AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2009
Mar 23, 2009
34519_dirs_2009-03-23_a189bdbf-9fe8-4933-9d2f-b32cc5b62e05.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2009-03-19
Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-03-19 | Common stock, par value $0.10 per share | P | 400 | $1.81 | Acquired | 440402 | Direct |
Footnotes
F1: This figure includes 185,173 of common stock, held by Arterio, Inc., a corporation owned soley by Mr. Rothschild.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23